AGM Statement

Oxford Instruments PLC 26 September 2006 26 September 2006 Oxford Instruments plc: Chairman's AGM Statement - 2006 Oxford Instruments plc is holding its Annual General Meeting today at which the Chairman, Nigel Keen, will make the following statement : "Last year we laid out our strategic agenda and defined our aim to exploit the Group's technology to become the leading provider of a new generation of tools and systems for work at the atomic and molecular level in the physical and bioscience sectors. In order to implement this strategy we have, as previously announced, increased our R & D spend. In addition, we have refocused the business towards the commercial realisation of transforming nanoscience into its applications. Increasingly, we provide total solutions to end-users and differentiate our products by both technical excellence and customer service. We have stepped up our programme of product introductions. The HyperSense Dynamic Nuclear Polarisation product launched earlier in the year has generated significant customer interest. HyperSense has the potential to revolutionise many analytical applications including the development of new pharmaceuticals. Two other major new products have been introduced in the year together with a number of upgrades of our existing product line to ensure our products maintain their leading positions. Our new commercial approach is also yielding benefits, with significant new orders obtained from customers in Europe, North America and the Far East. Current Trading Order levels and turnover for the year to date are ahead of the company's expectations. Following the closure of our undifferentiated NMR Magnet Business, the cost savings predicted in March this year are being realised. The post closure issues are being resolved and the on-site work needed to meet customer specification requirements in the bespoke magnet business continues. Despite the impact of unusually adverse dollar movements and the increase in the price of copper, which have affected us in recent months, the trading results of the half-year are expected to be better than at the same point last year, in line with the company's expectations. Oxford Instruments plc Tel: 01865 881437 Fax: 01865 884045 Jonathan Flint, Chief Executive Kevin Boyd, Group Finance Director Hogarth Partnership Limited Tel: 020 7357 9477 Fax: 020 7357 8533 Rachel Hirst Andrew Jaques Anthony Arthur Notes to Editors Oxford Instruments designs, supplies and supports high-technology tools, processes and solutions with a focus on physical science, bioscience, environmental and industrial research and applications. It provides solutions needed to advance fundamental nanoscience research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 40 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. The first technology business to be spun out from Oxford University over forty years ago, Oxford Instruments is now a global company with over 1,300 staff worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the Physical Science and Bioscience sectors. This involves the combination of core technologies in areas such as low temperature and high magnetic field environments, Nuclear Magnetic Resonance, X-ray electron and optical based metrology, and advanced growth, deposition and etching. Our products, expertise, and ideas address global issues such as energy, environment, terrorism and health and are part of the next generation of telecommunications, energy products, environmental measures, security devices, drug discovery and medical advances This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings